Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Horwitz

Showing results (511-520 of 717) with videos related to

Pageof 72
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 26, 2005
Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trialAlan Pollack, Alexandra L Hanlon, Eric M Horwitz, et al.
Brachytherapy|January 24, 2012
American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapyBrian J Davis, Eric M Horwitz, W Robert Lee, et al.
Psychological Assessment|November 28, 2022
Diagnostic accuracy of the Child and Adolescent Symptom Inventory (CASI-4R) substance use subscale in detecting substance use disorders in youthAngelina Pei-Tzu Tsai, Eric A Youngstrom, Kenneth D Gadow, et al.
CA: a Cancer Journal for Clinicians|June 29, 2026
Extranodal natural killer/T-cell lymphoma: From fatal to curableJie Xiong, Yok-Lam Kwong, Laurence de Leval, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2003
Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA eraDeborah A Kuban, Howard D Thames, Larry B Levy, et al.
International Journal of Radiation Oncology, Biology, Physics|October 4, 2005
PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysisMichael E Ray, Howard D Thames, Larry B Levy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2012
Phase II study of bendamustine in relapsed and refractory Hodgkin lymphomaAlison J Moskowitz, Paul A Hamlin, Miguel-Angel Perales, et al.
Cancer|September 1, 2006
Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysisEric M Horwitz, Lawrence B Levy, Howard D Thames, et al.
Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53|January 27, 2018
Diagnostic Accuracy of the CASI-4R Psychosis Subscale for Children Evaluated in Pediatric Outpatient ClinicsSabeen H Rizvi, Stephanie Salcedo, Eric A Youngstrom, et al.
Blood|March 7, 2018
Five-year outcomes for frontline brentuximab vedotin with CHP for CD30-expressing peripheral T-cell lymphomasMichelle A Fanale, Steven M Horwitz, Andres Forero-Torres, et al.
Pageof 72

Showing results (511-520 of 717) with videos related to

Sort By:
Pageof 72
International Journal of Radiation Oncology, Biology, Physics|October 26, 2005
Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trialAlan Pollack, Alexandra L Hanlon, Eric M Horwitz, et al.
Brachytherapy|January 24, 2012
American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapyBrian J Davis, Eric M Horwitz, W Robert Lee, et al.
Psychological Assessment|November 28, 2022
Diagnostic accuracy of the Child and Adolescent Symptom Inventory (CASI-4R) substance use subscale in detecting substance use disorders in youthAngelina Pei-Tzu Tsai, Eric A Youngstrom, Kenneth D Gadow, et al.
CA: a Cancer Journal for Clinicians|June 29, 2026
Extranodal natural killer/T-cell lymphoma: From fatal to curableJie Xiong, Yok-Lam Kwong, Laurence de Leval, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2003
Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA eraDeborah A Kuban, Howard D Thames, Larry B Levy, et al.
International Journal of Radiation Oncology, Biology, Physics|October 4, 2005
PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysisMichael E Ray, Howard D Thames, Larry B Levy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2012
Phase II study of bendamustine in relapsed and refractory Hodgkin lymphomaAlison J Moskowitz, Paul A Hamlin, Miguel-Angel Perales, et al.
Cancer|September 1, 2006
Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysisEric M Horwitz, Lawrence B Levy, Howard D Thames, et al.
Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53|January 27, 2018
Diagnostic Accuracy of the CASI-4R Psychosis Subscale for Children Evaluated in Pediatric Outpatient ClinicsSabeen H Rizvi, Stephanie Salcedo, Eric A Youngstrom, et al.
Blood|March 7, 2018
Five-year outcomes for frontline brentuximab vedotin with CHP for CD30-expressing peripheral T-cell lymphomasMichelle A Fanale, Steven M Horwitz, Andres Forero-Torres, et al.
Pageof 72